trending Market Intelligence /marketintelligence/en/news-insights/trending/S8YdNjm-vJF3GgSwy7hokg2 content esgSubNav
In This List

Swedish biopharma Hansa Medical to change name

Blog

Essential IR Insights Newsletter Fall - 2023

Case Study

A Corporation Clearly Pinpoints Activist Investor Activity

Blog

Insight Weekly: Bank mergers of equals return; energy tops S&P 500; green bond sales to rise

Blog

Insight Weekly: US companies boost liquidity; auto insurers hike rates; office sector risk rises


Swedish biopharma Hansa Medical to change name

Hansa Medical AB (publ) will change its name to Hansa Biopharma AB.

Bolagsverket, also known as the Swedish Companies Registration Office, approved the name change.

The name change was approved by shareholders during the biopharmaceutical company's Dec. 4 extraordinary general meeting.

Lund, Sweden-based Hansa, which focuses on treatment and prevention of rare and severe autoimmune conditions and transplant rejection, said the name change will be implemented in the next days and weeks, and the company's ticker has changed to HNSA from HMED.